Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) reported Q1 EPS of ($1.04), $0.31 better than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Cadrenal Therapeutics, Inc. (CVKD) click here.